189 related articles for article (PubMed ID: 25724225)
1. Y90 radioembolization of colorectal cancer liver metastases: response assessment by contrast-enhanced computed tomography with or without PET-CT guidance.
Vouche M; Salem R; Miller FH; Lemort M; Vanderlinden B; De Becker D; Hendlisz A; Flamen P
Clin Imaging; 2015; 39(3):454-62. PubMed ID: 25724225
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy of diffusion-weighted magnetic resonance imaging versus positron emission tomography/computed tomography for early response assessment of liver metastases to Y90-radioembolization.
Barabasch A; Kraemer NA; Ciritsis A; Hansen NL; Lierfeld M; Heinzel A; Trautwein C; Neumann U; Kuhl CK
Invest Radiol; 2015 Jun; 50(6):409-15. PubMed ID: 25763526
[TBL] [Abstract][Full Text] [Related]
3. Metabolic tumor volume and total lesion glycolysis on FDG-PET/CT can predict overall survival after (90)Y radioembolization of colorectal liver metastases: A comparison with SUVmax, SUVpeak, and RECIST 1.0.
Shady W; Kishore S; Gavane S; Do RK; Osborne JR; Ulaner GA; Gonen M; Ziv E; Boas FE; Sofocleous CT
Eur J Radiol; 2016 Jun; 85(6):1224-31. PubMed ID: 27161074
[TBL] [Abstract][Full Text] [Related]
4. Surrogate Imaging Biomarkers of Response of Colorectal Liver Metastases After Salvage Radioembolization Using 90Y-Loaded Resin Microspheres.
Shady W; Sotirchos VS; Do RK; Pandit-Taskar N; Carrasquillo JA; Gonen M; Sofocleous CT
AJR Am J Roentgenol; 2016 Sep; 207(3):661-70. PubMed ID: 27384594
[TBL] [Abstract][Full Text] [Related]
5. Colorectal liver metastasis after 90Y radioembolization therapy: pilot study of change in MDCT attenuation as a surrogate marker for future FDG PET response.
Tochetto SM; Töre HG; Chalian H; Yaghmai V
AJR Am J Roentgenol; 2012 May; 198(5):1093-9. PubMed ID: 22528898
[TBL] [Abstract][Full Text] [Related]
6. The role of early ¹⁸F-FDG PET/CT in prediction of progression-free survival after ⁹⁰Y radioembolization: comparison with RECIST and tumour density criteria.
Zerizer I; Al-Nahhas A; Towey D; Tait P; Ariff B; Wasan H; Hatice G; Habib N; Barwick T
Eur J Nucl Med Mol Imaging; 2012 Sep; 39(9):1391-9. PubMed ID: 22644713
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of quantitative parameters of 18F-FDG PET/CT in the evaluation of response to internal radiation therapy with yttrium-90 in patients with liver metastases of colorectal cancer.
Soydal C; Kucuk ON; Gecim EI; Bilgic S; Elhan AH
Nucl Med Commun; 2013 May; 34(5):501-6. PubMed ID: 23478586
[TBL] [Abstract][Full Text] [Related]
8. Anatomic versus Metabolic Tumor Response Assessment after Radioembolization Treatment.
Jongen JMJ; Rosenbaum CENM; Braat MNGJA; van den Bosch MAAJ; Sze DY; Kranenburg O; Borel Rinkes IHM; Lam MGEH; van den Hoven AF
J Vasc Interv Radiol; 2018 Feb; 29(2):244-253.e2. PubMed ID: 29249594
[TBL] [Abstract][Full Text] [Related]
9. Does multidetector CT attenuation change in colon cancer liver metastases treated with 90Y help predict metabolic activity at FDG PET?
Tochetto SM; Rezai P; Rezvani M; Nikolaidis P; Berggruen S; Atassi B; Salem R; Yaghmai V
Radiology; 2010 Apr; 255(1):164-72. PubMed ID: 20308454
[TBL] [Abstract][Full Text] [Related]
10. Quantitative Measurements of Enhancement on Preprocedure Triphasic CT Can Predict Response of Colorectal Liver Metastases to Radioembolization.
Boas FE; Brody LA; Erinjeri JP; Yarmohammadi H; Shady W; Kishore S; Sofocleous CT
AJR Am J Roentgenol; 2016 Sep; 207(3):671-5. PubMed ID: 27248430
[TBL] [Abstract][Full Text] [Related]
11. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver?
Selzner M; Hany TF; Wildbrett P; McCormack L; Kadry Z; Clavien PA
Ann Surg; 2004 Dec; 240(6):1027-34; discussion 1035-6. PubMed ID: 15570208
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of post-Yttrium 90 radioembolization therapy 18F-fluorodeoxyglucose positron emission tomography in patients with liver tumors.
Obrzut S; McCammack K; Badran KW; Balistreri A; Ou E; Nguyen BJ; Hoh CK; Rose SC
Clin Imaging; 2017; 42():43-49. PubMed ID: 27875761
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG PET/CT predicts survival after radioembolization of hepatic metastases from breast cancer.
Haug AR; Tiega Donfack BP; Trumm C; Zech CJ; Michl M; Laubender RP; Uebleis C; Bartenstein P; Heinemann V; Hacker M
J Nucl Med; 2012 Mar; 53(3):371-7. PubMed ID: 22331219
[TBL] [Abstract][Full Text] [Related]
14. Response assessment of colorectal liver metastases with contrast enhanced CT/18F-FDG PET.
García Vicente AM; Domínguez Ferreras E; Sánchez Pérez V; Poblete García VM; Villa Guzmán JC; Jiménez Aragón F; Pineda Pineda MD; Molino Trinidad C; Soriano Castrejón Á
Eur J Radiol; 2013 Jun; 82(6):e255-61. PubMed ID: 23414715
[TBL] [Abstract][Full Text] [Related]
15. Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI.
Wong CY; Salem R; Raman S; Gates VL; Dworkin HJ
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):815-20. PubMed ID: 12029557
[TBL] [Abstract][Full Text] [Related]
16. Early metabolic response assessment of breast cancer liver metastases: 4-week posttreatment FDG PET predicts survival after 90Y microsphere radioembolization.
Sabet A; Ries M; Al-Khalaf Y; Meyer C; Rudlowski C; Simon B; Khreish F; Ezziddin S
Nuklearmedizin; 2019 Jun; 58(3):242-248. PubMed ID: 31167272
[TBL] [Abstract][Full Text] [Related]
17. A Lesion-Based Response Prediction Model Using Pretherapy PET/CT Image Features for Y90 Radioembolization to Hepatic Malignancies.
Mehta R; Cai K; Kumar N; Knuttinen MG; Anderson TM; Lu H; Lu Y
Technol Cancer Res Treat; 2017 Oct; 16(5):620-629. PubMed ID: 27601017
[TBL] [Abstract][Full Text] [Related]
18. Early post-treatment FDG PET predicts survival after 90Y microsphere radioembolization in liver-dominant metastatic colorectal cancer.
Sabet A; Meyer C; Aouf A; Sabet A; Ghamari S; Pieper CC; Mayer K; Biersack HJ; Ezziddin S
Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):370-6. PubMed ID: 25351506
[TBL] [Abstract][Full Text] [Related]
19. Sequential FDG PET/CT in 90Y microsphere treatment of unresectable colorectal liver metastases.
Bienert M; McCook B; Carr BI; Geller DA; Sheetz M; Amesur N; Avril N
Eur J Nucl Med Mol Imaging; 2005 Jun; 32(6):723. PubMed ID: 15599525
[No Abstract] [Full Text] [Related]
20. Value of combined PET/CT for radiation planning in CT-guided percutaneous interstitial high-dose-rate single-fraction brachytherapy for colorectal liver metastases.
Steffen IG; Wust P; Rühl R; Grieser C; Schnapauff D; Lüdemann L; Grabik W; Ricke J; Amthauer H; Hamm B; Hänninen EL; Denecke T
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1178-85. PubMed ID: 20056343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
